PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
PETMED EXPRESS INC
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.15−0.03 (-2.54%)
Close on Oct 19, 2026
- Market cap
- $24.93M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
−$1.36 (−54.18%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
PETMED EXPRESS INC saw revenue fall 20.3% to $168.86M over the twelve months to Jun 30, 2026. Free cash flow was -$27.77M.
Revenue
$168.86M
-20.3% vs. a year earlier
Operating income
-$30.77M
TTM Q1 2027
Free cash flow
-$27.77M
TTM Q1 2027
EPS, diluted
-$1.38
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $24.93M
- P/E ratio
- –
- Price to sales
- 0.15
- Price to book
- 1.08
- Dividend yield
- 0.00%
- Free cash flow yield
- -111.39%
Fundamentals
- Revenue
- $168.86M
- Net income
- -$29.28M
- EPS, diluted
- -$1.38
- Free cash flow
- -$27.77M
- Book value per share
- $1.06
- Diluted shares
- 22M
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
$168.86M-20.3% YoY
Gross profit
$47.15M-26.9% YoY
Operating income
-$30.77M
Net income
-$29.28M
EPS, diluted
-$1.38
Free cash flow
-$27.77M
Reported periodTrailing twelve months